Volume 13, Number 7—July 2007
Antiretroviral Therapy during Tuberculosis Treatment and Marked Reduction in Death Rate of HIV-Infected Patients, Thailand1
|Characteristic||Adjusted OR (95% CI)|
|Antiretroviral therapy before or during TB treatment||0.2 (0.1–0.5)|
|Co-trimoxazole during TB treatment||1.1 (0.6–2.3)|
|CD4 count (cells/mm3)|
|Type, location of TB|
|Sputum smear–positive, pulmonary||Referent|
|Sputum smear–negative, pulmonary||1.3 (0.7–2.6)|
*Data not shown.
†TB, tuberculosis; OR, odds ratio; CI, confidence interval.
Data from this manuscript have been presented in part at the 36th UNION World Conference on Lung Health, Paris, October 2005, and the 15th Annual International AIDS Conference, Bangkok, July 2004.